RBD1119
/ Suzhou Ribo
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
October 01, 2025
Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=32 | Recruiting | Sponsor: Suzhou Ribo Life Science Co. Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open
June 30, 2025
Single Ascending Doses Phase I Study to Evaluate the Safety and Pharmacokinetics of RBD1119 in Healthy Participants
(clinicaltrials.gov)
- P1 | N=32 | Not yet recruiting | Sponsor: Suzhou Ribo Life Science Co. Ltd.
New P1 trial
1 to 2
Of
2
Go to page
1